Aptevo Therapeutics Inc (APVO): Next-Year EPS Estimate 48.09%
As of 2026-06-16, Aptevo Therapeutics Inc (APVO) has a next-year EPS growth estimate of 48.09%.
On 2026-06-16, analyst consensus for APVO's next-year EPS growth shifted from 70.21% to 48.09% — a negative change of 22.12 percentage points. Current-year growth is projected at 73.24%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 48.09%
- EPS growth this year
- 73.24%
- EPS next quarter (est)
- -$6.01
- Last price
- $4.54
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-16 | 48.09% | 73.24% | -$6.01 | $4.54 |
| 2026-03-27 | 70.21% | N/A | N/A | $4.27 |
| 2026-03-26 | 70.21% | N/A | N/A | $4.51 |
| 2026-03-26 | 70.21% | N/A | N/A | $4.51 |
| 2026-03-26 | 70.21% | N/A | N/A | $4.51 |
| 2026-03-25 | 70.21% | N/A | N/A | $4.42 |
| 2026-03-25 | 70.21% | N/A | N/A | $4.42 |
| 2026-03-25 | 70.21% | N/A | N/A | $4.42 |
| 2026-03-24 | 70.21% | N/A | N/A | $4.22 |
| 2026-03-24 | 70.21% | N/A | N/A | $4.22 |
| 2026-03-24 | 70.21% | N/A | N/A | $4.22 |
| 2026-03-23 | 70.21% | N/A | N/A | $4.49 |
| 2026-03-20 | 70.21% | N/A | N/A | $4.56 |
| 2026-03-19 | 70.21% | N/A | N/A | $4.50 |
| 2026-03-18 | 70.21% | N/A | N/A | $4.67 |
| 2026-03-17 | 70.21% | N/A | N/A | $4.63 |
Screen Performance
Aggregate stats across all 1792 tickers our top-EPS-revision screen has flagged over the past 76 days.
- Median return since detection
- +3.6%
- % of tickers in the green
- 57%
- Median return on winners
- +18.8%
- Large revisions captured
- 822
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Aptevo Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-16, Aptevo Therapeutics Inc (APVO) has a next-year EPS growth estimate of 48.09%, based on analyst consensus.
When was the latest EPS estimate revision for APVO?▾
The most recent revision occurred on 2026-06-16, when analysts adjusted the next-year EPS growth estimate from 70.21% to 48.09%.
What sector and industry does Aptevo Therapeutics Inc belong to?▾
Aptevo Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. APVO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Aptevo Therapeutics Inc (APVO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports